Plus Therapeutics, Inc. is a U.S. healthcare company developing precision diagnostics and targeted radiopharmaceuticals for CNS cancers. Its lead drug, rhenium (186Re) obisbemeda, targets recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers via localized delivery. Its subsidiary CNSide Diagnostics commercializes the CNSide cerebrospinal fluid tumor cell enumeration test. The company also holds 188RNL-BAM for liver cancers.
expected 2026-12-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001193125-26-104258 | EDGAR | 87K words |
| 2025-03-31 | 2024-12-31 | 0000950170-25-047698 | EDGAR | 82K words |
| 2024-03-05 | 2023-12-31 | 0000950170-24-025851 | EDGAR | 79K words |
| 2023-02-23 | 2022-12-31 | 0000950170-23-004099 | EDGAR | 65K words |
| 2022-02-24 | 2021-12-31 | 0001564590-22-006708 | EDGAR | — |
| 2021-02-22 | 2020-12-31 | 0001564590-21-007165 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001564590-20-014165 | EDGAR | — |
| 2019-03-29 | 2018-12-31 | 0001564590-19-010018 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001564590-18-005136 | EDGAR | — |
| 2017-03-24 | 2016-12-31 | 0001564590-17-005251 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001193125-26-352444 | EDGAR | 31K words |
| 2025-10-30 | 2025-09-30 | 0001193125-25-258596 | EDGAR | 37K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108874 | EDGAR | 36K words |
| 2025-05-30 | 2025-03-31 | 0000950170-25-079738 | EDGAR | 29K words |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127014 | EDGAR | 28K words |
| 2024-08-14 | 2024-06-30 | 0000950170-24-097091 | EDGAR | 26K words |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060395 | EDGAR | 23K words |
| 2023-10-31 | 2023-09-30 | 0000950170-23-056844 | EDGAR | 25K words |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042363 | EDGAR | 23K words |
| 2023-04-20 | 2023-03-31 | 0000950170-23-013671 | EDGAR | 22K words |
| 2022-10-20 | 2022-09-30 | 0000950170-22-019798 | EDGAR | — |
| 2022-07-21 | 2022-06-30 | 0001564590-22-026156 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-10 | 0001193125-26-387267 | EDGAR | 1K words |
| 2026-08-14 | 0001193125-26-352346 | EDGAR | 4K words |
| 2026-08-04 | 0001193125-26-332939 | EDGAR | 14K words |
| 2026-04-02 | 0001193125-26-140267 | EDGAR | 1K words |
| 2026-03-26 | 0001193125-26-125195 | EDGAR | 1K words |
| 2026-03-12 | 0001193125-26-104291 | EDGAR | 1K words |
| 2026-03-12 | 0001193125-26-104218 | EDGAR | 4K words |
| 2026-02-13 | 0001193125-26-051379 | EDGAR | 1K words |
| 2026-01-22 | 0001193125-26-018675 | EDGAR | 4K words |
| 2026-01-16 | 0001193125-26-015346 | EDGAR | 1K words |
431 total filings indexed. 399 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001095981 |
| Ticker | PSTV |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Headquarters | Houston, Texas |
| Website | https://www.plustherapeutics.com |
| Listed | 2000-11-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PSTV (~200 tokens, structured JSON with cryptographic provenance)